ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Pain Treatment Guide Published By NCCN, ACS

April 27, 2001

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

SOCMA Asks Congress for Carcinogen Classification Probe

March 25, 1988

1978-79 Budgets By Program Areas

June 3, 1977

In Brief: NIH AIDS William Paul To Step down; Aldige to Lead NCCR; Rimer Joins NCI

October 10, 1997